Together, the evidence supports a four-layer model—genotype → pathway architecture (mTORC1/2) → expression rewiring → phenotype—yielding three testable hypotheses: shared vs. tumor-specific drivers (H1), non-mutated network contributors (H2), and expression-defined mTOR dependency (H3). This evidence concerns the gene MTOR and neoplasm.